These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19772579)

  • 1. Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies.
    Mak A; Cheung MW; Ho RC; Cheak AA; Lau CS
    BMC Musculoskelet Disord; 2009 Sep; 10():113. PubMed ID: 19772579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of serious atrial fibrillation and stroke with use of bisphosphonates: evidence from a meta-analysis.
    Sharma A; Chatterjee S; Arbab-Zadeh A; Goyal S; Lichstein E; Ghosh J; Aikat S
    Chest; 2013 Oct; 144(4):1311-1322. PubMed ID: 23722644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates and atrial fibrillation: systematic review and meta-analysis.
    Loke YK; Jeevanantham V; Singh S
    Drug Saf; 2009; 32(3):219-28. PubMed ID: 19338379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of atrial fibrillation with use of oral and intravenous bisphosphonates.
    Sharma A; Einstein AJ; Vallakati A; Arbab-Zadeh A; Walker MD; Mukherjee D; Homel P; Borer JS; Lichstein E
    Am J Cardiol; 2014 Jun; 113(11):1815-21. PubMed ID: 24837258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of bisphosphonates on the risk of atrial fibrillation.
    Howard PA; Barnes BJ; Vacek JL; Chen W; Lai SM
    Am J Cardiovasc Drugs; 2010; 10(6):359-67. PubMed ID: 21090829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates and risk of atrial fibrillation: a meta-analysis.
    Kim SY; Kim MJ; Cadarette SM; Solomon DH
    Arthritis Res Ther; 2010; 12(1):R30. PubMed ID: 20170505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate use in women and the risk of atrial fibrillation: a systematic review and meta-analysis.
    Bhuriya R; Singh M; Molnar J; Arora R; Khosla S
    Int J Cardiol; 2010 Jul; 142(3):213-7. PubMed ID: 20051297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study.
    Herrera L; Leal I; Lapi F; Schuemie M; Arcoraci V; Cipriani F; Sessa E; Vaccheri A; Piccinni C; Staniscia T; Vestri A; Di Bari M; Corrao G; Zambon A; Gregori D; Carle F; Sturkenboom M; Mazzaglia G; Trifiro G
    Osteoporos Int; 2015 May; 26(5):1499-506. PubMed ID: 25752621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates in multiple myeloma: a network meta-analysis.
    Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
    Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of Bisphosphonate Therapy and Atrial Fibrillation/Flutter: Outcomes of Sleep Disorders in Older Men (MrOS Sleep) Study.
    Thadani SR; Ristow B; Blackwell T; Mehra R; Stone KL; Marcus GM; Varosy PD; Cummings SR; Cawthon PM;
    Chest; 2016 May; 149(5):1173-80. PubMed ID: 26836889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial fibrillation and bisphosphonate therapy.
    Pazianas M; Compston J; Huang CL
    J Bone Miner Res; 2010 Jan; 25(1):2-10. PubMed ID: 20091928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of bisphosphonate and risk of atrial fibrillation in older women with osteoporosis.
    Rhee CW; Lee J; Oh S; Choi NK; Park BJ
    Osteoporos Int; 2012 Jan; 23(1):247-54. PubMed ID: 21431993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between bisphosphonate use and stroke risk: a meta-analysis.
    Lin SM; Lin JY; Tu YK; Wu CH; Peng CC; Munir KM; Bukhari K; Jaggon K; Fu Y; Loh CH; Huang HK
    Osteoporos Int; 2023 Sep; 34(9):1625-1636. PubMed ID: 37249610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates and atrial fibrillation: clinical trial data suggest possible link.
    Prescrire Int; 2011 Apr; 20(115):96-7. PubMed ID: 21648212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of the cardiovascular safety of zoledronic acid and other bisphosphonates for the treatment of osteoporosis.
    John Camm A
    Clin Ther; 2010 Mar; 32(3):426-36. PubMed ID: 20399982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.
    Shepherd J; Jones J; Frampton GK; Tanajewski L; Turner D; Price A
    Health Technol Assess; 2008 Jun; 12(28):iii-iv, ix-95. PubMed ID: 18547499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsteroidal anti-inflammatory drugs and incidence of atrial fibrillation: a meta-analysis.
    Chokesuwattanaskul R; Chiengthong K; Thongprayoon C; Lertjitbanjong P; Bathini T; Ungprasert P; Cato LD; Mao MA; Cheungpasitporn W
    QJM; 2020 Feb; 113(2):79-85. PubMed ID: 32031227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alendronate and atrial fibrillation: a meta-analysis of randomized placebo-controlled clinical trials.
    Barrett-Connor E; Swern AS; Hustad CM; Bone HG; Liberman UA; Papapoulos S; Wang H; de Papp A; Santora AC
    Osteoporos Int; 2012 Jan; 23(1):233-45. PubMed ID: 21369791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates and risk of cardiovascular events: a meta-analysis.
    Kim DH; Rogers JR; Fulchino LA; Kim CA; Solomon DH; Kim SC
    PLoS One; 2015; 10(4):e0122646. PubMed ID: 25884398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.